Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate

NCT02268175 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Prostate Adenocarcinoma
Prostate Cancer
High Risk Prostate Cancer

Interventions

DRUG: Enzalutamide
DRUG: Abiraterone Acetate
DRUG: Prednisone
DRUG: Leuprolide Acetate

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]